Hologic Completes Sale of LIFECODES to Immucor
BEDFORD, Mass., March 22, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced that it has successfully completed its sale of the LIFECODES business unit to Immucor, Inc.
Hologic has received $85 million in cash (adjusted for working capital items) with the opportunity to earn a contingent payment of $10 million based on the achievement of certain financial targets for the calendar year 2013. The closing follows the receipt of all necessary regulatory approvals.
About Hologic, Inc.
Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems, and surgical products. The Company operates four core business units focused on diagnostics, breast health, GYN surgical and skeletal health. With a comprehensive suite of technologies and a robust research and development program, Hologic is committed to improving lives. The Company is headquartered in Massachusetts. For more information, visit www.hologic.com.
Hologic and associated logos are trademarks and/or registered trademarks of Hologic, Inc. and/or its subsidiaries in the United States and/or other countries.